Bio


Dr. Devika Das is a board-certified internal medicine doctor with Stanford Health Care. She is also a clinical assistant professor in the Department of Medicine, Division of Primary Care and Population Health at Stanford University School of Medicine.

Dr. Das is deeply committed to patient-centered care that provides comprehensive, personalized treatments tailored to her patients’ needs. In addition to primary and preventive care, she has special interests in fibromyalgia and mental health.

Dr. Das has presented to her peers at international and national meetings, including the International Congress of Controversies in Fibromyalgia, the Society of General Internal Medicine (SGIM) Annual Meeting, the American Diabetes Association (ADA) Scientific Sessions, and the American College of Physicians (ACP) Internal Medicine Meeting.

Dr. Das is a member of the ACP, the American Medical Association, the American Medical Women’s Association, and the SGIM.

Clinical Focus


  • Internal Medicine

Academic Appointments


Honors & Awards


  • Attitude, Commitment, and Excellence (ACE) Award, Mayo Clinic Internal Medicine Residency (2023, 2024)
  • Joseph D. Messler MD Fellowship in General Internal Medicine Award, Mayo Clinic Internal Medicine Residency (2024)
  • Senior Resident Excellence in Teaching Award, Mayo Clinic Internal Medicine Residency (2024)
  • Silver Level Certification, Mayo Clinic Quality Fellows Program

Boards, Advisory Committees, Professional Organizations


  • Member, Society of General Internal Medicine (SGIM) (2014 - Present)
  • Member, American Medical Women’s Association (AMWA) (2017 - Present)
  • Member, American Medical Association (AMA) (2019 - Present)
  • Member, American College of Physicians (ACP) (2018 - Present)

Professional Education


  • Fellowship, Mayo Clinic General Internal Medicine Fellowship, MN (2025)
  • Board Certification: American Board of Internal Medicine, Internal Medicine (2024)
  • Residency: Mayo Clinic Internal Medicine Residency (2024) MN
  • Medical Education: Mayo Clinic Alix School of Medicine (2021) AZ

All Publications


  • 78-Year-Old Woman With Altered Mental Status and Hypoxia. Mayo Clinic proceedings Jiang, L., Das, D. M., Ducharme-Smith, A. L. 2025; 100 (8): 1420-1425

    View details for DOI 10.1016/j.mayocp.2024.07.029

    View details for PubMedID 40358576

  • Twin Pregnancy Complicated by Gestational Diabetes Mellitus: Maternal and Neonatal Outcomes. Journal of the Endocrine Society Das, D., Christie, H. E., Hegazi, M., Takawy, M., Pone, K. A., Vella, A., Egan, A. M. 2024; 8 (6): bvae075

    Abstract

    The risk of gestational diabetes mellitus (GDM) in twin pregnancies is more than double that of singleton pregnancies. Although twin pregnancies present unique challenges for fetal growth and prenatal management, the approach to GDM diagnosis and treatment is the same regardless of plurality. Data on pregnancy outcomes for individuals with GDM and a twin pregnancy are limited and conflicting.To describe the maternal characteristics associated with GDM in twin pregnancies and to assess the associated pregnancy outcomes compared to twin pregnancies unaffected by GDM.A retrospective cohort study was conducted at Mayo Clinic, Rochester, Minnesota, USA, and included predominantly Causasian women aged 18 to 45 years who received prenatal care for a twin pregnancy from 2017-2022. Maternal characteristics and a broad spectrum of pregnancy outcomes were evaluated. Universal GDM screening involved a 50 g oral glucose challenge test +/- a 100 g oral glucose tolerance test.GDM was diagnosed in 23% pregnancies (n = 104/452). Compared to those without, women with GDM had known risk factors including a higher prepregnancy body mass index (31.1vs 26.3 kg/m2; P < .01) and a prior history of GDM (21.7 vs 5.9%; P < .01). There were no differences in maternal pregnancy complications or neonatal outcomes between groups. Attendance at postpartum glucose testing among women with GDM was poor at 27.9% (29/104).These data suggest that women with twin pregnancies share a similar GDM risk profile to those with singleton pregnancies and provide reassuring evidence that current management for GDM twin pregnancies produces similar outcomes to twin pregnancies without GDM.

    View details for DOI 10.1210/jendso/bvae075

    View details for PubMedID 38698871

    View details for PubMedCentralID PMC11065348

  • Expanding Liver Transplant Opportunities in Older Patients With Nonconventional Grafts. The Journal of surgical research Egbert, L. K., Ohara, S. Y., Das, D., Brooks, A., Mahdi, G., Aqel, B., Buckner Petty, S. A., Mathur, A. K., Moss, A., Reddy, K. S., Jadlowiec, C. C. 2023; 288: 140-147

    Abstract

    Broader use of donation after circulatory death (DCD) and nonconventional grafts for liver transplant helps reduce disparities in organ availability. Limited data, however, exists on outcomes specific to nonconventional graft utilization in older patients. As such, this study aimed to investigate outcomes specific to conventional and nonconventional graft utilization in recipients > 70 y of age.1-to-3 matching based on recipient sex, Model for End-Stage Liver Disease score, and donor type was performed on patients ≥70 and <70 y of age who underwent liver transplant alone at Mayo Clinic Arizona between 2015 and 2020. Primary outcomes were posttransplant patient and liver allograft survival for recipients greater than or less than 70 y of age. Secondary outcomes included grafts utilization patterns, hospital length of stay, need for reoperation, biliary complications and disposition at time of hospital discharge.In this cohort, 36.1% of grafts came from DCD donors, 17.4% were postcross clamp offers, and 20.8% were nationally allocated. Median recipient ages were 59 and 71 y (P < 0.01). Recipients had similar Intensive care unit (P = 0.82) and hospital (P = 0.14) lengths of stay, and there were no differences in patient (P = 0.68) or graft (P = 0.38) survival. When comparing donation after brain death and DCD grafts in those >70 y, there were no differences in patient (P = 0.89) or graft (P = 0.71) survival.Excellent outcomes can be achieved in older recipients, even with use of nonconventional grafts. Expanded use of nonconventional grafts can help facilitate transplant opportunities in older patients.

    View details for DOI 10.1016/j.jss.2023.01.017

    View details for PubMedID 36966594

  • Human Trafficking Education: A Pilot Study of Integration into Medical School Curriculum. Journal of medical education and curricular development Das, D. M., Talbott, J. M., Dutcher, J. S., Buras, M., Lim, E., Vegunta, S., David, P., Kling, J. M. 2023; 10: 23821205231164088

    Abstract

    Few medical schools incorporate formal education on human trafficking (HT) and sex trafficking (ST) into their curriculum. Our objective was to develop, implement, and evaluate education on HT and ST in the first-year medical student curriculum.The curriculum included a standardized patient (SP) experience and lecture. As part of their mandatory sexual health course, students interviewed an SP who presented with red flags for ST and then participated in a discussion led by a physician-facilitator in an observed small group setting. A multiple-choice survey to assess knowledge about HT and ST was developed and administered to students before and after the SP interview.Of the 50 first-year medical students, 29 (58%) participated in the survey. Compared with the students' baseline scores (according to the percentage of correct responses), scores after the educational intervention showed a significant increase in percentage correct on questions related to trafficking definition and scope (elder care, P = .01; landscaping, P = .03); victim identification (P < .001); referral to services (P < .001); legal issues (P = .01); and security (P < .001). On the basis of the feedback, a 2-hour lecture, which was adapted from the American Medical Women's Association-Physicians Against the Trafficking of Humans "Learn to Identify and Fight Trafficking" training, was presented the next year to all first-year medical students as part of their longitudinal clinical skills course and before the SP case. Curriculum objectives included learning trafficking definitions, victim/survivor identification, intersections with health care, the local impact of HT, and available resources.This curriculum fulfills course objectives and could be replicated at other institutions. Further evaluation of this pilot curriculum is necessary to evaluate its effectiveness.

    View details for DOI 10.1177/23821205231164088

    View details for PubMedID 37324053

    View details for PubMedCentralID PMC10265360

  • Reassessing Geographic, Logistical, and Cold Ischemia Cutoffs in Liver Transplantation. Progress in transplantation (Aliso Viejo, Calif.) Ohara, S., Lizaola-Mayo, B., Macdonough, E., Morgan, P., Das, D., Egbert, L., Brooks, A., Mathur, A. K., Aqel, B., Reddy, K. S., Jadlowiec, C. C. 2023; 33 (2): 168-174

    Abstract

    Liver acceptance patterns vary significantly between transplant centers. Data pertaining to outcomes of livers declined by local and regional centers and allocated nationally remains limited.The objective was to compare post-liver transplant outcomes between liver allografts transplanted as a result of national and local-regional allocation.This was a retrospective evaluation of 109 nationally allocated liver allografts used for transplant by a single center. Outcomes of nationally allocated grafts were compared to standard allocation grafts (N  =  505) during the same period.Recipients of nationally allocated grafts had lower model for end stage liver disease scores (17 vs 22, P  =  .001). Nationally allocated grafts were more likely to be post-cross clamp offers (29.4% vs 13.4%, P  =  .001) and have longer cold ischemia times (median hours 7.8 vs 5.5, P  =  .001). Early allograft dysfunction was common (54.1% vs 52.5%, P  =  .75) and did not impact hospital length of stay (median 5 vs 6 days, P  =  .89). There were no differences in biliary complications (P  =  .11). There were no differences in patient (P  =  .88) or graft survival (P  =  .35). In a multivariate model, after accounting for differences in cold ischemia time and posttransplant biliary complications, nationally allocated grafts were not associated with increased risk for graft loss (HR 0.9, 95% CI 0.4-1.8). Abnormal liver biopsy findings (33.0%) followed by donor donation after circulatory death status (22.9%) were the most common reasons for decline by local-regional centers.Despite longer cold ischemia times, patient and graft survival outcomes remain excellent and comparable to those seen from standard allocation grafts.

    View details for DOI 10.1177/15269248231164169

    View details for PubMedID 37013356

  • Association of DGF and Early Readmissions on Outcomes Following Kidney Transplantation. Transplant international : official journal of the European Society for Organ Transplantation Jadlowiec, C. C., Frasco, P., Macdonough, E., Wagler, J., Das, D., Budhiraja, P., Mathur, A. K., Katariya, N., Reddy, K., Khamash, H., Heilman, R. 2022; 35: 10849

    Abstract

    Concerns regarding outcomes and early resource utilization are potential deterrents to broader use of kidneys at risk for delayed graft function (DGF). We assessed outcomes specific to kidneys with DGF that required early readmission following transplant. Three groups were identified: 1) recipients with DGF not requiring readmission, 2) recipients with DGF having an isolated readmission, and 3) recipients with DGF requiring ≥2 readmissions. Most recipients either required a single readmission (26.8%, n = 247) or no readmission (56.1%, n = 517); 17.1% (n = 158), had ≥2 readmissions. Recipients requiring ≥2 readmissions were likely to be diabetic (53.8%, p = 0.04) and have longer dialysis vintage (p = 0.01). Duration of DGF was longer with increasing number of readmissions (p < 0.001). There were no differences in patient survival for those with DGF and 0, 1 and ≥2 readmissions (p = 0.13). Graft survival, however, was lower for those with ≥2 readmissions (p < 0.0001). This remained true when accounting for death-censored graft loss (p = 0.0012). Additional subgroup analysis was performed on mate kidneys with and without DGF and mate kidneys, both with DGF, with and without readmissions. For these subgroups, there were no differences in patient or graft survival. As a whole, patients with DGF have excellent outcomes, however, patients with DGF requiring ≥2 readmissions have lower graft survival. A better understanding of recipient variables contributing to multiple readmissions may allow for improvements in the utilization of DGF at-risk kidneys.

    View details for DOI 10.3389/ti.2022.10849

    View details for PubMedID 36620699

    View details for PubMedCentralID PMC9817097

  • Donation after circulatory death transplant outcomes using livers recovered by local surgeons. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society Jadlowiec, C. C., Macdonough, E., Pont, K., Valenti, K., Lizaola-Mayo, B., Brooks, A., Das, D., Heilman, R., Mathur, A. K., Hewitt, W., Moss, A., Aqel, B., Reddy, K. S. 2022; 28 (11): 1726-1734

    Abstract

    Donation after circulatory death (DCD) liver transplantation (LT) outcomes have been attributed to multiple variables, including procurement surgeon recovery techniques. Outcomes of 196 DCD LTs at Mayo Clinic Arizona were analyzed based on graft recovery by a surgeon from our center (transplant procurement team [TPT]) versus a local procurement surgeon (non-TPT [NTPT]). A standard recovery technique was used for all TPT livers. The recovery technique used by the NTPT was left to the discretion of that surgeon. A total of 129 (65.8%) grafts were recovered by our TPT, 67 (34.2%) by the NTPT. Recipient age (p = 0.43), Model for End-Stage Liver Disease score (median 17 vs. 18; p = 0.22), and donor warm ischemia time (median 21.0 vs. 21.5; p = 0.86) were similar between the TPT and NTPT groups. NTPT livers had longer cold ischemia times (6.5 vs. 5.0 median hours; p < 0.001). Early allograft dysfunction (80.6% vs. 76.1%; p = 0.42) and primary nonfunction (0.8% vs. 0.0%; p = 0.47) were similar. Ischemic cholangiopathy (IC) treated with endoscopy occurred in 18.6% and 11.9% of TPT and NTPT grafts (p = 0.23). At last follow-up, approximately half of those requiring endoscopy were undergoing a stent-free trial (58.3% TPT; 50.0% NTPT; p = 0.68). IC requiring re-LT in the first year occurred in 0.8% (n = 1) of TPT and 3.0% (n = 2) of NTPT grafts (p = 0.23). There were no differences in patient (hazard ratio [HR], 1.95; 95% confidence interval [CI], 0.76-5.03; p = 0.23) or graft (HR, 1.99; 95% CI, 0.98-4.09; p = 0.10) survival rates. Graft survival at 1 year was 91.5% for TPT grafts and 95.5% for NTPT grafts. Excellent outcomes can be achieved using NTPT for the recovery of DCD livers. There may be an opportunity to expand the use of DCD livers in the United States by increasing the use of NTPT.

    View details for DOI 10.1002/lt.26461

    View details for PubMedID 35332655

    View details for PubMedCentralID PMC9790574

  • Outcomes of dual kidney transplants from high KDPI kidneys are superior compared to single kidney high KDPI transplants at 1 year. Clinical transplantation Das, D., Wagler, J., Ohara, S., Nguyen, M., Frasco, P. E., Smith, M., Khamash, H., Mathur, A. K., Budhiraja, P., Reddy, K., Heilman, R., Jadlowiec, C. 2022; 36 (8): e14737

    Abstract

    Dual kidney transplantation (DKT), utilizing two adult kidneys from the same donor for one recipient, has been used as a way to expand the available donor pool. These kidneys often come from high Kidney Donor Profile Index donors (KDPI > 85%). Data comparing outcomes between high KDPI DKT and single kidney transplants (SKT) remain limited. We assessed outcomes of 336 high KDPI kidney transplants performed at our center; 11.0% (n = 37) were DKT. Recipients of DKT were older (P = .02) and donors had a higher KDPI score (median 96% vs. 91%, P < .0001). DKT operative time was higher compared to SKT (+1.4 hours, P < .0001). There were no differences in delayed graft function (54.1% vs. 51.5%, P = .77) and hospital length of stay (median 4.0 vs. 3.0 days, P = .21) between DKT and SKT. Grade I Clavien-Dindo complications occurred in 8.1% of DKT and 13.7% of SKT (P = .008). There were no grade IVa, IVb, or V complications in either group. DKT had more glomerulosclerosis (P = .04), interstitial fibrosis (P = .02), tubular atrophy (P = .01), and arterial thickening (P = .03) on 1-year protocol biopsies. Estimated glomerular filtration was higher for DKT at 1- (P = .004) and 2-years post-transplant (P = .01). There were no differences in patient (HR 1.3, 95% CI .5-3.3, P = .58) or graft (HR 1.1, 95% CI .5-2.3, P = .83) survival. Good outcomes can be achieved with DKT using high KDPI kidneys with moderate chronic changes. DKT is a good option to help further utilize high KDPI kidneys and minimize discard.

    View details for DOI 10.1111/ctr.14737

    View details for PubMedID 35633507

  • Overcoming Mismatch Concerns for Adult Recipients of Small Pediatric Deceased Donor Kidneys. Transplantation proceedings Das, D. M., Heilman, R. L., Khamash, H. A., Mathur, A. K., Singer, A. L., Reddy, K. S., Jadlowiec, C. C. 2021; 53 (5): 1509-1513

    Abstract

    Kidneys from very young pediatric donors continue to be underutilized. To reduce discard, the Organ Procurement and Transplantation Network (OPTN) policy was recently updated to allow kidneys from donors weighing <18 kg to be recovered en bloc.We reviewed our center's experience with kidney transplantation in adult recipients of <18 kg pediatric donor kidneys to assess renal function outcomes specific to solitary vs en bloc usage.The majority of <18 kg donors were used en bloc (n = 39, 72.2% vs n = 15, 27.8%). Donor weight (kg) was similar between the 2 groups (12.3 ± 3.2 vs 14.1 ± 2.5, P = .05). Recipient weight was lower in the solitary kidney group (P = .01). Both groups had a similar donor-to-recipient body weight ratio (0.24 ± 0.3 vs 0.18 ± 0.3, P = .51). The solitary kidney group had a lower estimated glomerular filtration rate at 1 (56.9 ± 24.3 vs 81.8 ± 24.8, P = .01) and 2 years (72 ± 18.6 vs 93.7 ± 21.6, P = .03). By 2 years, both groups had an average estimated glomerular filtration rate >60 mL/min. Kidney allograft growth occurred in both groups, with the largest increase occurring the first month posttransplant (11.9%, 18.6%, P < .0001).For pediatric donors weighing <18 kg, improvements in renal function continue beyond the first posttransplant year. Risk for hyperfiltration injury appears low and renal mass-recipient mass matching is useful in guiding decision-making for solitary vs en bloc utilization.

    View details for DOI 10.1016/j.transproceed.2021.03.030

    View details for PubMedID 33892934

  • Transplant outcomes using kidneys from high KDPI acute kidney injury donors. Clinical transplantation Jadlowiec, C. C., Hanna, W. A., Ninan, J., Ryan, M. S., Das, D. M., Smith, M., Khamash, H., Mathur, A. K., Singer, A., Moss, A., Reddy, K. S., Heilman, R. L. 2021; 35 (5): e14279

    Abstract

    Kidney transplant (KT) outcomes from high kidney donor profile index (KDPI ≥85%) donors with acute kidney injury (AKI) remain underreported. KT from 172 high KDPI Acute Kidney Injury Network (AKIN) stage 0-1 donors and 76 high KDPI AKIN stage 2-3 donors from a single center were retrospectively assessed. The AKIN 2-3 cohort had more delayed graft function (71% vs. 37%, p < .001). At one year, there were no differences in the estimated glomerular filtration rate (44 ± 17 vs. 46 ± 18, p = .42) or fibrosis on protocol biopsy (ci, p = .85). Donor terminal creatinine (p = .59) and length of delayed graft function (p = .39) did not impact one-year eGFR. There were more primary nonfunction (PNF) events in the high KDPI AKIN 2-3 group (5.3% vs. 0.6%, p = .02). With a median follow-up of 3.8 years, one-year death-censored graft failure was 3.5% for AKIN 0-1 and 14.5% for AKIN 2-3 (HR 2.40, 95% CI 1.24-4.63, p = .01). Although AKIN stage 2-3 high KDPI kidneys had comparable one-year eGFR to AKIN stage 0-1 high KDPI kidneys, there were more PNF occurrences and one-year death-censored graft survival was reduced. Given these findings, additional precautions should be undertaken when assessing and utilizing kidneys from severe AKI high KDPI donors.

    View details for DOI 10.1111/ctr.14279

    View details for PubMedID 33690907

  • Early technical pancreas failure in Simultaneous Pancreas-Kidney Recipients does not impact renal allograft outcomes. Clinical transplantation Das, D. M., Huskey, J. L., Harbell, J. W., Heilman, R. L., Singer, A. L., Mathur, A., Neville, M. R., Morgan, P., Reddy, K. S., Jadlowiec, C. C. 2021; 35 (1): e14138

    Abstract

    Early pancreas loss in simultaneous pancreas-kidney (SPK) transplants has been associated with longer perioperative recovery and reduced kidney allograft function. We assessed the impact of early pancreas allograft failure on transplant outcomes in a contemporary cohort of SPK patients (n = 218). Early pancreas allograft loss occurred in 12.8% (n = 28) of recipients. Delayed graft function (DGF) was more common (21.4% vs. 7.4%, p = 0.03) in the early pancreas loss group, but there were no differences in hospital length of stay (median 6.5 vs. 7.0, p = 0.22), surgical wound complications (p = 0.12), or rejection episodes occurring in the first year (p = 0.87). Despite differences in DGF, both groups had excellent renal function at 1 year post-transplant (eGFR 64.1 ± 20.8 vs. 65.8 ± 22.9, p = 0.75). There were no differences in patient (HR 0.58, 95% CI 0.18-1.87, p = 0.26) or kidney allograft survival (HR 0.84, 95% CI 0.23-3.06, p = 0.77). One- and 2-year protocol kidney biopsies were comparable between the groups and showed minimal chronic changes; the early pancreas loss group showed more cv changes at 2 years (p = 0.04). Current data demonstrate good outcomes and excellent kidney allograft function following early pancreas loss.

    View details for DOI 10.1111/ctr.14138

    View details for PubMedID 33131111

  • Identifying and Addressing Barriers to Systemic Thrombolysis for Acute Ischemic Stroke in the Inpatient Setting: A Quality Improvement Initiative. Mayo Clinic proceedings. Innovations, quality & outcomes Pines, A. R., Das, D. M., Bhatt, S. K., Shiue, H. J., Dawit, S., Vanderhye, V. K., Sands, K. A. 2020; 4 (6): 657-666

    Abstract

    To identify barriers to inpatient alteplase administration and implement an interdisciplinary program to reduce time to systemic thrombolysis.Compared with patients presenting to the emergency department with an acute ischemic stroke (AIS), inpatients are delayed in receiving alteplase for systemic thrombolysis. Institutional AIS metrics were extracted from the electronic medical records of patients presenting as an inpatient stroke alert. All patients who received alteplase for AIS were included in the analysis. A gap analysis was used to assess institutional deficiencies. An interdisciplinary intervention was initiated to address these deficiencies. Efficacy was measured with pre- and postintervention surveys and institutional AIS metric analysis. Statistical significance was determined using the Student t test. We identified 5 patients (mean age, 73 years; 100% (5/5) male; 80% (4/5) white) who met inclusion criteria for the preintervention period (January 1, 2017, to December 31, 2017) and 10 patients (mean age, 71 years; 50% male; 80% white) for the postintervention period (October 31, 2018, to July 1, 2020).We found barriers to rapid delivery of thrombolytic treatment to include alteplase availability and comfort with bedside reconstitution. Interdisciplinary intervention strategies consisted of stocking alteplase on additional floors as well as structured education and hands-on alteplase reconstitution simulations for resident physicians. The mean time from stroke alert to thrombolysis was shorter postintervention than preintervention (57.4 minutes vs 77.8 minutes; P=.03).A coordinated interdisciplinary approach is effective in reducing time to systemic thrombolysis in patients experiencing AIS in the inpatient setting. A similar program could be implemented at other institutions to improve AIS treatment.

    View details for DOI 10.1016/j.mayocpiqo.2020.07.009

    View details for PubMedID 33367211

    View details for PubMedCentralID PMC7749238

  • Nonconvulsive status epilepticus secondary to acute porphyria crisis. Epilepsy & behavior case reports Dawit, S., Bhatt, S. K., Das, D. M., Pines, A. R., Shiue, H. J., Goodman, B. P., Drazkowski, J. F., Sirven, J. I. 2019; 11: 43-46

    Abstract

    Both variegate and acute intermittent porphyria can manifest with various neurological symptoms. Although acute symptomatic seizures have been previously described, they are typically tonic-clonic and focal impaired awareness seizures. Convulsive status epilepticus and epilepsia partialis continua are rare and have been described on a case report basis. To our knowledge, there are no previously reported cases describing non-convulsive status epilepticus (NCSE) with electroencephalogram (EEG) documentation in the setting of acute porphyria crisis. We report a unique presentation of NCSE, which resolved after administering levetiracetam in a patient with variegate porphyria, without a known seizure disorder.

    View details for DOI 10.1016/j.ebcr.2018.11.002

    View details for PubMedID 30671344

    View details for PubMedCentralID PMC6327909

  • Teaching NeuroImages: Congenital variant misdiagnosed as cerebral venous sinus thrombosis: Clinical pitfall. Neurology Dawit, S., Das, D. M., Acierno, M. D., O'Carroll, C. B. 2019; 92 (17): e2064-e2065

    View details for DOI 10.1212/WNL.0000000000007372

    View details for PubMedID 31010916

  • Quantitative Methods to Investigate the 4D Dynamics of Heterochromatic Repair Sites in Drosophila Cells. Methods in enzymology Caridi, C. P., Delabaere, L., Tjong, H., Hopp, H., Das, D., Alber, F., Chiolo, I. 2018; 601: 359-389

    Abstract

    Heterochromatin is mostly composed of long stretches of repeated DNA sequences prone to ectopic recombination during double-strand break (DSB) repair. In Drosophila, "safe" homologous recombination (HR) repair of heterochromatic DSBs relies on a striking relocalization of repair sites to the nuclear periphery. Central to understanding heterochromatin repair is the ability to investigate the 4D dynamics (movement in space and time) of repair sites. A specific challenge of these studies is preventing phototoxicity and photobleaching effects while imaging the sample over long periods of time, and with sufficient time points and Z-stacks to track repair foci over time. Here we describe an optimized approach for high-resolution live imaging of heterochromatic DSBs in Drosophila cells, with a specific emphasis on the fluorescent markers and imaging setup used to capture the motion of repair foci over long-time periods. We detail approaches that minimize photobleaching and phototoxicity with a DeltaVision widefield deconvolution microscope, and image processing techniques for signal recovery postimaging using SoftWorX and Imaris software. We present a method to derive mean square displacement curves revealing some of the biophysical properties of the motion. Finally, we describe a method in R to identify tracts of directed motions (DMs) in mixed trajectories. These approaches enable a deeper understanding of the mechanisms of heterochromatin dynamics and genome stability in the three-dimensional context of the nucleus and have broad applicability in the field of nuclear dynamics.

    View details for DOI 10.1016/bs.mie.2017.11.033

    View details for PubMedID 29523239

    View details for PubMedCentralID PMC6021022